The role of BK channels in control of vascular tone is well established; thus, targeting of BK channels by pharmacological activators may have the potential to treat conditions such as ischemia-reperfusion injury, overactive bladder, and erectile dysfunction. Here, KCNMA1 is linked to erectile dysfunction.